Augtyro (repotrectinib)

**Product type:** Human Prescription Drug

**Active ingredient:** REPOTRECTINIB

**Strength:** 40 mg/1

**Dosage form:** Capsule

**Route:** Oral

**Labeler:** E.R. Squibb & Sons, L.L.C.

**Marketing category:** NDA (NDA218213)

**Pharmacologic class:** Cytochrome P450 3A4 Inducers [MoA], Kinase Inhibitor [EPC], Proto-Oncogene Tyrosine-Protein Kinase ROS1 Inhibitors [MoA], Tropomyosin Receptor Tyrosine Kinase A Inhibitors [MoA], Tropomyosin Receptor Tyrosine Kinase B Inhibitors [MoA], Tropomyosin Receptor Tyrosine Kinase C Inhibitors [MoA]